Antibody Mediated Rejection: Are We There Yet?

  • Glen P. WestallEmail author
  • Lucy C. Sullivan


The diagnosis, management and treatment of antibody-mediated rejection (AMR) following lung transplantation remains challenging, but is associated with both acute and chronic lung allograft dysfunction (CLAD). Confidence for the diagnosis of AMR increases according to how many of the diagnostic tenets are present that include anti-HLA donor specific antibodies (DSA), C4d staining and histological changes centered around the capillary septum. Future studies on pulmonary AMR will be facilitated by the recent publication of a consensus statement on AMR in lung transplantation.


Lung transplantation Antibody-mediated rejection (AMR) Donor specific antibodies (DSA) Humoral rejection Chronic lung allograft dysfunction (CLAD) 



The Alfred’s Lung Transplant Service gratefully acknowledges the Lungitude Foundation for their research and education support.


  1. 1.
    Meehan AC, Sullivan LC, Mifsud NA, Brooks AG, Snell GI, Kotsimbos TC, Westall GP. Natural killer cell activation in the lung allograft early posttransplantation. Transplantation. 2010;89:756–63.CrossRefPubMedGoogle Scholar
  2. 2.
    Legris T, Picard C, Todorova D, Lyonnet L, Laporte C, Dumoulin C, Nicolino-Brunet C, Daniel L, Loundou A, Morange S, Bataille S, Vacher-Coponat H, Moal V, Berland Y, Dignat-George F, Burtey S, Paul P. Antibody-dependent NK cell activation is associated with late kidney allograft dysfunction and the complement-independent alloreactive potential of donor-specific antibodies. Front Immunol. 2016;7:288.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kim M, Townsend KR, Wood IG, Boukedes S, Guleria I, Gabardi S, El-Chemaly S, Camp PC, Chandraker AK, Milford EL, Goldberg HJ. Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates. Am J Respir Crit Care Med. 2014;189:1234–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Tinckam KJ, Keshavjee S, Chaparro C, Barth D, Azad S, Binnie M, Chow CW, de Perrot M, Pierre AF, Waddell TK, Yasufuku K, Cypel M, Singer LG. Survival in sensitized lung transplant recipients with perioperative desensitization. Am J Transplant. 2015;15:417–26.CrossRefPubMedGoogle Scholar
  5. 5.
    Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr, Neil D, Reinsmoen NL, Snyder LD, Sweet S, Tyan D, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi A. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016;35:397–406.CrossRefPubMedGoogle Scholar
  6. 6.
    Vandermeulen E, Verleden SE, Bellon H, Ruttens D, Lammertyn E, Claes S, Vandooren J, Ugarte-Berzal E, Schols D, Emonds MP, Van Raemdonck DE, Opdenakker G, Verleden GM, Vos R, Vanaudenaerde BM. Humoral immunity in phenotypes of chronic lung allograft dysfunction: a broncho-alveolar lavage fluid analysis. Transpl Immunol. 2016;38:27–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Walton DC, Hiho SJ, Cantwell LS, Diviney MB, Wright ST, Snell GI, Paraskeva MA, Westall GP. HLA matching at the eplet level protects against chronic lung allograft dysfunction. Am J Transplant. 2016;16:2695–703.CrossRefPubMedGoogle Scholar
  8. 8.
    Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, Suberbielle C, Fremeaux-Bacchi V, Mejean A, Desgrandchamps F, Anglicheau D, Nochy D, Charron D, Empana JP, Delahousse M, Legendre C, Glotz D, Hill GS, Zeevi A, Jouven X. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013;369:1215–26.CrossRefPubMedGoogle Scholar
  9. 9.
    Huibers MM, Gareau AJ, Beerthuijzen JM, Siera-de Koning E, van Kuik J, Kamburova EG, Vink A, de Jonge N, Lee TD, Otten HG, de Weger RA. Donor-specific antibodies are produced locally in ectopic lymphoid structures in cardiac allografts. Am J Transplant. 2017;17:246–54.CrossRefPubMedGoogle Scholar
  10. 10.
    Cozzi E, Calabrese F, Schiavon M, Feltracco P, Seveso M, Carollo C, Loy M, Cardillo M, Rea F. Immediate and catastrophic antibody-mediated rejection in a lung transplant recipient with anti-angiotensin II receptor type 1 and anti-endothelin-1 receptor type a antibodies. Am J Transplant. 2017;17:557–64.CrossRefPubMedGoogle Scholar
  11. 11.
    Reinsmoen NL, Mirocha J, Ensor CR, Marrari M, Chaux G, Levine DJ, Zhang X, Zeevi A. A 3-center study reveals new insights into the impact of non-HLA antibodies on lung transplantation outcome. Transplantation. 2017;101:1215–21.CrossRefPubMedGoogle Scholar
  12. 12.
    Aguilar PR, Carpenter D, Ritter J, Yusen RD, Witt CA, Byers DE, Mohanakumar T, Kreisel D, Trulock EP, Hachem RR. The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation. Am J Transplant. 2017;18:936.CrossRefPubMedGoogle Scholar
  13. 13.
    Roden AC, Maleszewski JJ, Yi ES, Jenkins SM, Gandhi MJ, Scott JP, Aubry MC. Reproducibility of complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies. J Heart Lung Transplant. 2014;33:1223–32.CrossRefPubMedGoogle Scholar
  14. 14.
    Westall GP, Snell GI, McLean C, Kotsimbos T, Williams T, Magro C. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant. 2008;27:722–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Orandi BJ, Lonze BE, Jackson A, Terezakis S, Kraus ES, Alachkar N, Bagnasco SM, Segev DL, Orens JB, Montgomery RA. Splenic irradiation for the treatment of severe antibody-mediated rejection. Am J Transplant. 2016;16:3041–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Wallace WD, Li N, Andersen CB, Arrossi AV, Askar M, Berry GJ, Denicola MM, Neil DA, Pavlisko EN, Reed EF, Remmelink M, Weigt SS, Weynand B, Zhang JQ, Budev MM, Farver CF. Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies. J Heart Lung Transplant. 2016;35:40–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Berry G, Burke M, Andersen C, Angelini A, Bruneval P, Calabrese F, Fishbein MC, Goddard M, Leone O, Maleszewski J, Marboe C, Miller D, Neil D, Padera R, Rassl D, Revello M, Rice A, Stewart S, Yousem SA. Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant. 2013;32:14–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Dawson KL, Parulekar A, Seethamraju H. Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab. J Heart Lung Transplant. 2012;31:1325–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13:176–89.CrossRefPubMedGoogle Scholar
  20. 20.
    Otani S, Davis AK, Cantwell L, Ivulich S, Pham A, Paraskeva MA, Snell GI, Westall GP. Evolving experience of treating antibody-mediated rejection following lung transplantation. Transpl Immunol. 2014;31:75–80.CrossRefPubMedGoogle Scholar
  21. 21.
    Vacha M, Chery G, Hulbert A, Byrns J, Benedetti C, Finlen Copeland CA, Gray A, Onwuemene O, Palmer SM, Snyder LD. Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: does it work? Clin Transpl. 2017;31:e12886.CrossRefGoogle Scholar
  22. 22.
    Witt CA, Gaut JP, Yusen RD, Byers DE, Iuppa JA, Bennett Bain K, Alexander Patterson G, Mohanakumar T, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2013;32:1034–40.CrossRefPubMedGoogle Scholar
  23. 23.
    Roux A, Bendib Le Lan I, Holifanjaniaina S, Thomas KA, Hamid AM, Picard C, Grenet D, De Miranda S, Douvry B, Beaumont-Azuar L, Sage E, Devaquet J, Cuquemelle E, Le Guen M, Spreafico R, Suberbielle-Boissel C, Stern M, Parquin F, Foch Lung Transplantation Group. Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics. Am J Transplant. 2016;16:1216–28.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Lung Transplant ServiceAlfred Hospital and Monash UniversityMelbourneAustralia
  2. 2.Department of Microbiology and ImmunologyThe University of Melbourne at The Peter Doherty Institute for Infection and ImmunityMelbourneAustralia

Personalised recommendations